Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Cancer Cell
|
November 5, 2021
Rejuvenating dysfunctional T cells in ovarian cancer: CD28 is the license to kill
Florian Uhlitz, Dmitriy Zamarin
FEBS Letters
|
July 5, 2017
A compendium of ERK targets
Evrim B Ünal, Florian Uhlitz, Nils Blüthgen
Molecular Systems Biology
|
May 5, 2017
An immediate-late gene expression module decodes ERK signal duration
Florian Uhlitz, Anja Sieber, Emanuel Wyler, et al.
Nature Communications
|
January 4, 2018
Perturbation-response genes reveal signaling footprints in cancer gene expression
Michael Schubert, Bertram Klinger, Martina Klünemann, et al.
Advances in Biological Regulation
|
January 12, 2021
Mutation-specific effects of NRAS oncogenes in colorectal cancer cells
Natalia Kuhn, Bertram Klinger, Florian Uhlitz, et al.
Nature Communications
|
July 20, 2023
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector
Nicholas Ceglia, Zachary Sethna, Samuel S Freeman, et al.
Cell
|
November 20, 2025
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
Michelle von Locquenghien, Pascale Zwicky, Ken Xie, et al.
Nature Communications
|
July 4, 2019
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
Raphael Brandt, Thomas Sell, Mareen Lüthen, et al.
Oncogene
|
October 19, 2021
Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma
Philip Bischoff, Alexandra Trinks, Benedikt Obermayer, et al.
Cell Reports
|
September 23, 2020
SFPQ Depletion Is Synthetically Lethal with BRAF<sup>V600E</sup> in Colorectal Cancer Cells
Kathleen Klotz-Noack, Bertram Klinger, Maria Rivera, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Cancer Cell
|
November 5, 2021
Rejuvenating dysfunctional T cells in ovarian cancer: CD28 is the license to kill
Florian Uhlitz, Dmitriy Zamarin
FEBS Letters
|
July 5, 2017
A compendium of ERK targets
Evrim B Ünal, Florian Uhlitz, Nils Blüthgen
Molecular Systems Biology
|
May 5, 2017
An immediate-late gene expression module decodes ERK signal duration
Florian Uhlitz, Anja Sieber, Emanuel Wyler, et al.
Nature Communications
|
January 4, 2018
Perturbation-response genes reveal signaling footprints in cancer gene expression
Michael Schubert, Bertram Klinger, Martina Klünemann, et al.
Advances in Biological Regulation
|
January 12, 2021
Mutation-specific effects of NRAS oncogenes in colorectal cancer cells
Natalia Kuhn, Bertram Klinger, Florian Uhlitz, et al.
Nature Communications
|
July 20, 2023
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector
Nicholas Ceglia, Zachary Sethna, Samuel S Freeman, et al.
Cell
|
November 20, 2025
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
Michelle von Locquenghien, Pascale Zwicky, Ken Xie, et al.
Nature Communications
|
July 4, 2019
Cell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
Raphael Brandt, Thomas Sell, Mareen Lüthen, et al.
Oncogene
|
October 19, 2021
Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma
Philip Bischoff, Alexandra Trinks, Benedikt Obermayer, et al.
Cell Reports
|
September 23, 2020
SFPQ Depletion Is Synthetically Lethal with BRAF<sup>V600E</sup> in Colorectal Cancer Cells
Kathleen Klotz-Noack, Bertram Klinger, Maria Rivera, et al.
Page
of 2